NCT01382784

Brief Summary

There is growing evidence that psoriasis is a systemic disorder which enhances atherosclerosis and the risk of cardiovascular disease. Epidemiological studies have shown an independent association between psoriasis and atherosclerosis, stroke and coronary artery disease. The main goal of this on-going study is to register data which will enable the identification of new markers of atherosclerosis activity and carotid plaque instability in patients with severe psoriasis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 27, 2011

Completed
Last Updated

June 27, 2011

Status Verified

May 1, 2011

First QC Date

June 24, 2011

Last Update Submit

June 24, 2011

Conditions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who have had psoriasis for more than 5 years are being admitted to the study. The assessments include: clinical data, treatment, platelet aggregation and blood viscosity, serum markers and mediators of atherosclerosis, carotid IMT and plaque burden assessed by Color Duplex ultrasound. The patients are recruited from our dermatological department (in and outdoor patients)

You may qualify if:

  • \>18 years old, psoriasis for more than 5 years, moderate to severe psoriasis (PASI \>10 or systemic treatment)

You may not qualify if:

  • familiar hypercholesterolemia, ongoing infections and cancer disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dermatological Department, OUS

Oslo, Norway

Location

Oslo university Hospital, Dermatological dept

Oslo, Norway

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood, tissue

MeSH Terms

Conditions

PsoriasisCardiovascular Diseases

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 24, 2011

First Posted

June 27, 2011

Study Start

May 1, 2011

Last Updated

June 27, 2011

Record last verified: 2011-05

Locations